Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1961 1
1965 1
1977 2
1980 1
1985 6
1986 26
1987 38
1988 57
1989 45
1990 55
1991 46
1992 63
1993 69
1994 36
1995 36
1996 40
1997 29
1998 40
1999 55
2000 34
2001 51
2002 35
2003 55
2004 51
2005 42
2006 51
2007 69
2008 66
2009 49
2010 84
2011 55
2012 55
2013 51
2014 48
2015 37
2016 50
2017 35
2018 40
2019 30
2020 35
2021 19
2022 16
2023 25
2024 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,654 results

Results by year

Filters applied: . Clear all
Page 1
Hib vaccine in India: a case for universal immunization.
Kumar A, Singh M, Thumburu KK, Jaiswal N, Kaur H, Sharma S, Agarwal A. Kumar A, et al. Vaccine. 2013 Aug 20;31(37):3763-5. doi: 10.1016/j.vaccine.2013.06.067. Epub 2013 Jul 3. Vaccine. 2013. PMID: 23830975 No abstract available.
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Martinón-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R; PRI02C study group. Martinón-Torres F, et al. Vaccine. 2017 Jun 27;35(30):3764-3772. doi: 10.1016/j.vaccine.2017.05.043. Epub 2017 Jun 2. Vaccine. 2017. PMID: 28583305 Clinical Trial.
DTaP5-IPV-HB-Hib vaccine is a fully-liquid, combination hexavalent vaccine. This phase III, open-label, multicentre study conducted in Spain, evaluated the immune response to all DTaP5-IPV-HB-Hib antigens when the vaccine was used in a mixed hexa/penta/hexa primary …
DTaP5-IPV-HB-Hib vaccine is a fully-liquid, combination hexavalent vaccine. This phase III, open-label, multicentre study cond …
Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data.
Sharma A, Kaplan WA, Chokshi M, Hasan Farooqui H, Zodpey SP. Sharma A, et al. BMJ Open. 2015 Feb 23;5(2):e007038. doi: 10.1136/bmjopen-2014-007038. BMJ Open. 2015. PMID: 25712822 Free PMC article.
Per capita gross domestic product is a key explanatory variable. The annual Hib vaccine uptake and the 2009-2012 coverage levels were several times higher in the capital/metropolitan cities than the rest of the state, suggesting inequity in access to Hib v …
Per capita gross domestic product is a key explanatory variable. The annual Hib vaccine uptake and the 2009-2012 coverage leve …
Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.
Townsend-Payne K, Ladhani SN, Findlow H, Slack M, Borrow R. Townsend-Payne K, et al. Vaccine. 2016 Jul 25;34(34):3931-4. doi: 10.1016/j.vaccine.2016.06.033. Epub 2016 Jun 20. Vaccine. 2016. PMID: 27317452
Using a recently-validated serum bactericidal antibody (SBA) assay, we tested convalescent sera from 127 Hib vaccine failure cases against clinical Hib strains expressing 1-5 copies of the capsulation locus. SBA titres correlated weakly with anti-capsular IgG antibo …
Using a recently-validated serum bactericidal antibody (SBA) assay, we tested convalescent sera from 127 Hib vaccine failure c …
Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
Verma R, Khanna P, Chawla S, Bairwa M, Prinja S, Rajput M. Verma R, et al. Hum Vaccin. 2011 Nov;7(11):1158-60. doi: 10.4161/hv.7.11.17683. Epub 2011 Nov 1. Hum Vaccin. 2011. PMID: 22048118
Hib vaccine is safe, highly effective and readily available in the market. Hib vaccine has been shown to be > 95% efficacious in diverse populations around the world. Globally, hundreds of millions of doses of Hib vaccine have been adm …
Hib vaccine is safe, highly effective and readily available in the market. Hib vaccine has been shown to be > …
The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States.
Geier DA, Kern JK, Homme KG, Geier MR. Geier DA, et al. Int J Hyg Environ Health. 2018 May;221(4):677-683. doi: 10.1016/j.ijheh.2018.03.004. Epub 2018 Mar 14. Int J Hyg Environ Health. 2018. PMID: 29573974
Subjects were included if they received either of these two Hib vaccine formulations between 1995 and 1999. Cases were defined as adverse event reports with a reported outcome of autism, developmental delay, psychomotor delay, or NDs in general. ...Cases of reported …
Subjects were included if they received either of these two Hib vaccine formulations between 1995 and 1999. Cases were defined …
Immunogenicity and safety of a DTaP-IPV/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan.
Nakayama T, Vidor E, Tsuzuki D, Nishina S, Sasaki T, Ishii Y, Mizukami H, Tsuge H. Nakayama T, et al. J Infect Chemother. 2020 Jul;26(7):651-659. doi: 10.1016/j.jiac.2019.11.012. Epub 2020 Apr 16. J Infect Chemother. 2020. PMID: 32307307 Free article. Clinical Trial.
The immunogenicity and safety of a primary vaccination series and booster of a combined pentavalent DTaP-IPV/Hib vaccine were evaluated and compared to separate administration of DTaP-IPV and Hib in Japanese infants. ...CONCLUSIONS: These data show the good immunoge …
The immunogenicity and safety of a primary vaccination series and booster of a combined pentavalent DTaP-IPV/Hib vaccine were …
Vaccine preventable meningitis in Malaysia: epidemiology and management.
McNeil HC, Jefferies JM, Clarke SC. McNeil HC, et al. Expert Rev Anti Infect Ther. 2015 Jun;13(6):705-14. doi: 10.1586/14787210.2015.1033401. Expert Rev Anti Infect Ther. 2015. PMID: 25962101 Review.
Much of the disease burden can be avoided by immunization, particularly against Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae. Despite inclusion of the Hib vaccine in the National Immunisation Programme and the licensure of pneumococcal vaccines, …
Much of the disease burden can be avoided by immunization, particularly against Haemophilus influenzae type b (Hib) and Streptococcus pneumo …
[Haemophilus influenzae type b vaccine].
Katsuta T, Saitoh A. Katsuta T, et al. Nihon Rinsho. 2011 Sep;69(9):1589-93. Nihon Rinsho. 2011. PMID: 21922758 Review. Japanese.
Haemophilus influenzae type b (Hib) vaccine has been included in the national Immunization Program in more than 120 countries around the world and its effectiveness and safety have been confirmed. ...It is important to make an effort to fill the "vaccine gap" betwee …
Haemophilus influenzae type b (Hib) vaccine has been included in the national Immunization Program in more than 120 countries …
1,654 results